027 — Washington D.C., District of Columbia

027 is a clinical research site located in Washington D.C., District of Columbia, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

027 has participated in 1 clinical trials.

Therapeutic areas: Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine.

Sponsors: UCB Pharma.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 027?

027 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 027 conducted?

027 has 1 clinical trials on record. Their work covers Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine.

Is 027 accredited by Crixeo Health?

027 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 027?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.